effect of time to relapse on os in mcl following autohct
Published 3 years ago • 61 plays • Length 3:34Download video MP4
Download video MP3
Similar videos
-
2:14
addressing the high rate of disease relapse following allosct in patients with aml
-
3:00
the devastating effects of relapsed or refractory aml
-
1:19
developing a score to predicting early relapse post-auto-hct
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
15:57
aggregasi trombosit menggunakan alat aggram by helena laboratories
-
7:40
#48-normal hemostasis - an overview
-
1:23
strymon timeline - effects loop: orbit flanger - demo
-
3:18
granulocytes & t-cells as biomarkers for relapse in cml following discontinuation of tkis
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
2:42
the use of targeted therapy to prevent relapse post-transplant
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:03
relapse incidence post-allosct with ptcy for aml in cr1
-
4:03
discontinuing treatment and predicting relapse in cml
-
1:08
the potential of tcrs for relapse management
-
3:02
mrd monitoring by ngs in aml over time: revealing predictors of relapse
-
1:02
the impact of sequencing in aml
-
3:44
new mrd monitoring techniques could be most accurate predictor of relapse in mm patients
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
3:58
extended follow-up of glofitamab monotherapy in r/r lbcl: durability of cr and likelihood of crs
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
4:31
labmt: impact of treatment prior to allogenic hct in mds